Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    BIOSIMILARS 2019 - Biosimilars and Biologics Summit 2019

    View: 461

    Website https://www.lexisconferences.com/biosimilars | Want to Edit it Edit Freely

    Category Biosimilars; Biologics; Biopharmaceutical; Biotherapeutics

    Deadline: August 31, 2019 | Date: September 16, 2019-September 17, 2019

    Venue/Country: London, U.K.

    Updated: 2018-10-31 20:21:48 (GMT+9)

    Call For Papers - CFP

    Lexis is delighted to invite all to the upcoming Biosimilars & Biologics Summit 2019 which is going to be held on September 16 - 17, 2019 at London, U.K.

    Biosimilars 2019 is a phenomenal event which will be bringing together people from different domains of pharmaceutical and biopharmaceutical world such as researchers, analysts, regulatory and IPR Attorneys, Business Development Teams, Professors, PhD research scholars and more to discuss on the topics related to Biosimilars and Biologics. This international event also includes Keynote talks, Plenary sessions, Exhibitions, Poster Presentations, Workshop.

    Biosimilars 2019 aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars and biologics. This International conference will incorporate world renowned keynote speakers, plenary speeches, young research forum, poster presentations, technical workshops and career guidance sessions

    CALL FOR SUBMISSIONS

    Current challenges in developing Biosimilars and Biologics

    Biosimilars Vs Biologics

    Biosimilars in Oncology

    Biopharmaceuticals

    Bioequivalence Assessment of Biosimilars

    Biological Products

    Regulatory approach for Biosimilars

    Intellectual Property Rights

    Clinical trials of Biosimilars and Biologics

    Globalization of Biosimilars

    Biosimilar Monoclonal antibody

    Drug Delivery and Development

    Current trends in Pharmaceutical industry

    Challenges in Biosimilars pharmacovigilance

    Brexit effect on Biosimilars

    Biosimilars Legal issues and BPCI acts

    GMP, GCP and Quality Control of Biopharmaceuticals

    Protein Biotherapeutics

    Biosimilars Vs Biobetters

    Pharma pricing and market access


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.